TFF Pharmaceuticals, Inc. (0K3.F)
| Previous Close | 4.6800 |
| Open | 4.9600 |
| Bid | 5.1500 x N/A |
| Ask | 5.4000 x N/A |
| Day's Range | 4.9600 - 4.9600 |
| 52 Week Range | 3.7600 - 9.7500 |
| Volume | |
| Avg. Volume | 23 |
| Market Cap | 125.844M |
| Beta (5Y Monthly) | 2.13 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
TFF Pharmaceuticals to Participate at the H.C. Wainwright Global Investment Conference
FORT WORTH, Texas, May 20, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that President and CEO Glenn Mattes will be virtually participating in the H.C. Wainwright Global Investment Conference being held May 23 - 26, 2022. Company management will also be participating in virtual one-o
- GlobeNewswire
TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
Announced Collaboration with Catalent to Further Expand Thin Film Freezing Applications with a Focus on Biologic Drug Development Announced Second CRADA Agreement with USAMRIID and Geneva Foundation to Develop Novel Therapies Using Thin Film Freezing to Combat SARS-CoV-2, Ebola, and Marburg Viruses Initiated Phase 2 Trials of Inhaled Voriconazole Powder and Inhaled Tacrolimus Powder With Interim Data for Each Program Expected Later in 2022 Significant Progress Made in Inhaled Niclosamide Powder
- GlobeNewswire
TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD)
Thin Film Freezing Technology Co-Inventor Dr. Robert O. Williams III to Deliver Platform Presentation of Data on Stabilizing and Delivering Antivirals, Antibodies and Vaccines using Thin Film Freezing Technology in the Fight Against COVID-19 Members of Dr. Williams’ Lab at The University of Texas at Austin will Present Five Posters at RDD Meeting Research Showcases Versatility and Differentiation of the Thin Film Freezing Technology Platform and its Potential to Address Multiple Challenges in Dr
